Replicative response, immunophenotype, and functional activity of monocyte-derived versus CD34+-derived dendritic cells following exposure to various expansion and maturational stimuli

Clinical Immunology

Volumn 98, Issue 2, 2001, Pages 280-292

  Chen, Bohao ^a   Stiff, Patrick ^a   Sloan, George ^a   Kash, Joseph ^a   Manjunath, Rajini ^a   Pathasarathy, Mala ^a   Oldenburg, David ^a   Foreman, Kimberly E ^a   Nickoloff, Brian J ^a  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

CD34; CD40L; Dendritic cells; Immunotherapy; Monocytes; Vaccines

Indexed keywords

CD34 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ARTICLE; CELL MATURATION; CRYOPRESERVATION; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMOBILIZED CELL; IMMUNE RESPONSE; IMMUNOPHENOTYPING; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; STIMULUS RESPONSE; T LYMPHOCYTE ACTIVATION;

EID: 0035122420     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1006/clim.2000.4968     Document Type: Article

References (26)

1. The dendritic cell system and its role in immunogenicity
2. Not all spindle-shaped cells in the dermis are fibroblasts: Recognition of the "collagen-associated dendrophage"
3. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
4. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
5. + progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3 interferon-gamma, and erythropoietin
6. + hematopoietic progenitor cells of the bone marrow and peripheral blood
7. + blood progenitors for anticancer therapy
8. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability
9. + hematopoietic progenitor cells in cancer patients
10. + hematopoietic progenitor cells toward distinct dendritic cell subsets of the Birbeck granule and MHC-positive Langerhans cell and the interdigitating dendritic cell type
11. + peripheral blood progenitor cell and monocyte derived dendritic cells: A comparative analysis
12. + cells in static and continuous perfusion cultures
13. + cells
14. Dendritic cells as the terminal stage of monocyte differentiation
15. Dendritic cells and the control of immunity
16. Presentation of exogenous protein antigen by dendritic cells to T cell clones: Intact protein is presented best by immature, epidermal Langerhans cells
17. Phagocytosis of antigens by Langerhans cells in vitro
18. Immature dendritic cells phagocytose apoptotic cells via αvβ5 and CD36, and cross-present antigens to cytotoxic T lymphocytes
19. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
20. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
21. Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen
22. Vaccination of melanoma patients with peptide - Or tumor lysate - Pulsed dendritic cells
23. Proliferation in monocyte-derived dendritic cell cultures is caused by progenitor cells capable of myeloid differentiation
24. Autologous dendritic cells derived from CD34+ T progenitors and from monocytes are not functionally equivalent antigen-presenting cells in the induction of Melan-A/Mart-1 specific CTLs from peripheral blood lymphocytes of melanoma patients with low frequency of CTL precursor
25. Flt3-ligand mobilization of dendritic cells in patients with metastatic colon cancer
26. Macrophage and retinal pigment epithelium phagocytosis: Apoptotic cells and photoreceptors compete for αvβ3 and αvβ5 integrins, and protein kinase C regulates αvβ5 binding and cytoskeletal linkage